Patent Assignment
Reel/Frame 051999/0038
Assignment of Assignor's Interest
Recorded: 2020-03-03
Pages: 9
Assignor
ADC THERAPEUTICS SA
Executed: 2018-10-22
Assignee
MEDIMMUNE LIMITED
MILSTEIN BUILDING, GRANTA PARK, CAMBRIDGE, CB21 6GH, UNITED KINGDOM
Covered Property
(1)
Dosage Regimes for the Administration of an Anti-CD25 Adc
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 27, 2020
From: WUERTHNER, JENS
To: ADC THERAPEUTICS SA
Reel/Frame 051944/0891 →
Assignment of Assignor's Interest
Feb 27, 2020
From: FEINGOLD, JAY MARSHALL
To: ADC THERAPEUTICS AMERICA, INC.
Reel/Frame 051944/0902 →
Assignment of Assignor's Interest
Feb 28, 2020
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 051964/0947 →
Assignment of Assignor's Interest
Feb 28, 2020
From: ADC THERAPEUTICS AMERICA, INC.
To: ADC THERAPEUTICS SA
Reel/Frame 051964/0861 →
Security Interest
May 19, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P., AS GRANTEE
Reel/Frame 052696/0247 →
Security Interest
Jun 12, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P.
Reel/Frame 052930/0614 →
Termination and Release of Patent Security Agreement
Aug 16, 2022
From: DEERFIELD PARTNERS, L.P.
To: ADC THERAPEUTICS SA
Reel/Frame 061200/0750 →
Patent Security Agreement
Dec 27, 2022
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 062228/0763 →